glycine has been researched along with Androgen-Independent Prostatic Cancer in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Adler, D | 1 |
Menon, R | 1 |
Braun, M | 1 |
Offermann, A | 1 |
Queisser, A | 1 |
Boehm, D | 1 |
Vogel, W | 1 |
Rüenauver, K | 1 |
Ruiz, C | 1 |
Zellweger, T | 1 |
Svensson, M | 1 |
Andren, O | 1 |
Kristiansen, G | 1 |
Wernert, N | 1 |
Bubendorf, L | 1 |
Kirfel, J | 1 |
Biskup, S | 1 |
Perner, S | 1 |
Wei, X | 1 |
Zhou, P | 1 |
Lin, X | 1 |
Lin, Y | 1 |
Wu, S | 1 |
Diao, P | 1 |
Xie, H | 1 |
Xie, K | 1 |
Tang, P | 1 |
2 other studies available for glycine and Androgen-Independent Prostatic Cancer
Article | Year |
---|---|
MED15, encoding a subunit of the mediator complex, is overexpressed at high frequency in castration-resistant prostate cancer.
Topics: Aged; Androgens; Cell Line, Tumor; Cell Proliferation; Gene Expression Regulation, Neoplastic; Glyci | 2014 |
MLN2238 synergizes BH3 mimetic ABT-263 in castration-resistant prostate cancer cells by induction of NOXA.
Topics: Aniline Compounds; Antineoplastic Combined Chemotherapy Protocols; Apoptosis; BH3 Interacting Domain | 2014 |